Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism

PURPOSE: We recently demonstrated that histone deacetylase (HDAC) inhibitors can “reprogram” differentiated triple-negative breast cancer cells to become quiescent stem-like cancer cells. We hypothesized that the metabolic state of such cells differs from that of their differentiated progeny. RESULT...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Debeb, Bisrat G., Lacerda, Lara, Larson, Richard, Wolfe, Adam R., Krishnamurthy, Savitri, Reuben, James M., Ueno, Naoto T., Gilcrease, Michael, Woodward, Wendy A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053589/
https://ncbi.nlm.nih.gov/pubmed/27078845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8631
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller